Opus Genetics to Participate in Leading Medical Conferences in May 2026
Opus Genetics announced that its leadership team will present data at four major ophthalmology and industry conferences in May 2026, including the ARVO Annual Meeting and ASGCT. The presentations will feature preliminary results from the ongoing Phase 1b/2a OPGx-BEST1 study as well as preclinical work on OPGx-RHO and LCA5 programs.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.